Latest Court Approvals News

The Abercrombie Group, led by hummgroup’s Board Chair, has tabled a non-binding $0.58 per share offer to acquire the remaining shares of hummgroup, signaling a potential ownership shift at a premium to market price.

PointsBet shareholders have voted in favour of the proposed $1.20 per share acquisition by MIXI, Inc, marking a significant premium and clearing a key hurdle ahead of court approval.

Treasury Wine Estates has secured Supreme Court approval for a $65 million settlement of a consolidated shareholder class action, allowing the company to focus on its strategic goals without admitting liability.

Meridian Energy has won shareholder approval to acquire NZ Windfarms, paving the way for a landmark repowering of the Te Rere Hau wind farm that could multiply renewable output sevenfold.

Donaco International Limited has entered a binding acquisition scheme with On Nut Road Limited at A$0.045 per share, deemed fair and reasonable by an independent expert. The Board unanimously recommends shareholder approval ahead of the August 2025 vote.

The Reject Shop held a virtual Scheme Meeting approving Dollarama's $6.68 per share acquisition offer, reflecting a substantial premium and unanimous board support. The deal now awaits Federal Court approval, with implementation expected by late July.

Envirosuite has secured a key regulatory green light from FIRB for its acquisition by Ideagen, moving the proposed Scheme of Arrangement closer to shareholder approval.

Shift4 Payments, LLC has entered into a definitive scheme implementation agreement to acquire Smartpay Holdings Limited at NZ$1.20 per share, subject to regulatory and shareholder approvals. The transaction outlines a detailed timetable and conditions, including Overseas Investment Office consent and court sanction.

New World Resources has agreed to an enhanced acquisition proposal from Central Asia Metals, including increased cash consideration and a strategic A$10 million placement to accelerate project development.

Clean Seas Seafood updates shareholders on a revised equity conversion ratio for the Yumbah scrip alternative following significant impairment charges by Yumbah Aquaculture. The scheme meeting is now set for 8 July 2025.

Mayne Pharma shareholders have overwhelmingly approved a scheme for Cosette Pharmaceuticals to acquire the company, setting the stage for a pivotal court hearing later this year.

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.